Inborn errors of immunity (primary immunodeficiencies)

Abstract Primary immunodeficiencies (PID), now often referred to as inborn errors of immunity (IEI), are a large heterogeneous group of disorders that result from deficiencies in immune system development and/or function. IEIs can be broadly classified as disorders of adaptive immunity (e.g., combin...

Full description

Saved in:
Bibliographic Details
Main Authors: Vy H. D. Kim, Julia E. M. Upton, Beata Derfalvi, Kyla J. Hildebrand, Christine McCusker
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Allergy, Asthma & Clinical Immunology
Online Access:https://doi.org/10.1186/s13223-024-00938-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544545261584384
author Vy H. D. Kim
Julia E. M. Upton
Beata Derfalvi
Kyla J. Hildebrand
Christine McCusker
author_facet Vy H. D. Kim
Julia E. M. Upton
Beata Derfalvi
Kyla J. Hildebrand
Christine McCusker
author_sort Vy H. D. Kim
collection DOAJ
description Abstract Primary immunodeficiencies (PID), now often referred to as inborn errors of immunity (IEI), are a large heterogeneous group of disorders that result from deficiencies in immune system development and/or function. IEIs can be broadly classified as disorders of adaptive immunity (e.g., combined or humoral immunodeficiencies) or of innate immunity (e.g., phagocyte and complement disorders). Although the clinical manifestations of IEIs are highly variable, traditionally many disorders involve an increased susceptibility to infection. Research in recent years has underscored how IEI can present with features other than infection such as: severe atopy, autoimmunity, autoinflammation, lymphoproliferation, and/or malignancy resulting from immune dysregulation. Early consultation with a clinical immunologist is essential, as timely diagnosis and treatment are imperative for preventing significant disease-associated morbidity and mortality. The treatment of IEIs is complex and generally requires both supportive and definitive strategies, including but not limited to, immunoglobulin replacement therapy, antibiotic prophylaxis, immune response modifiers, and hematopoietic stem cell transplantation. This article provides an overview of the major categories of IEIs and strategies for the appropriate diagnosis and management of these disorders.
format Article
id doaj-art-c7da4fd77aaf4ce5ae2a3b92aade5d22
institution Kabale University
issn 1710-1492
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Allergy, Asthma & Clinical Immunology
spelling doaj-art-c7da4fd77aaf4ce5ae2a3b92aade5d222025-01-12T12:28:05ZengBMCAllergy, Asthma & Clinical Immunology1710-14922025-01-0120S311710.1186/s13223-024-00938-zInborn errors of immunity (primary immunodeficiencies)Vy H. D. Kim0Julia E. M. Upton1Beata Derfalvi2Kyla J. Hildebrand3Christine McCusker4Division of Immunology and Allergy, Department of Pediatrics, The Hospital for Sick Children, Temerty School of Medicine, University of TorontoDivision of Immunology and Allergy, Department of Pediatrics, The Hospital for Sick Children, Temerty School of Medicine, University of TorontoDivision of Immunology, IWK Health Centre, Department of Pediatrics, Dalhousie UniversityDivision of Immunology, Department of Pediatrics, BC Children’s HospitalDivision of Allergy and Clinical Immunology, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health CentreAbstract Primary immunodeficiencies (PID), now often referred to as inborn errors of immunity (IEI), are a large heterogeneous group of disorders that result from deficiencies in immune system development and/or function. IEIs can be broadly classified as disorders of adaptive immunity (e.g., combined or humoral immunodeficiencies) or of innate immunity (e.g., phagocyte and complement disorders). Although the clinical manifestations of IEIs are highly variable, traditionally many disorders involve an increased susceptibility to infection. Research in recent years has underscored how IEI can present with features other than infection such as: severe atopy, autoimmunity, autoinflammation, lymphoproliferation, and/or malignancy resulting from immune dysregulation. Early consultation with a clinical immunologist is essential, as timely diagnosis and treatment are imperative for preventing significant disease-associated morbidity and mortality. The treatment of IEIs is complex and generally requires both supportive and definitive strategies, including but not limited to, immunoglobulin replacement therapy, antibiotic prophylaxis, immune response modifiers, and hematopoietic stem cell transplantation. This article provides an overview of the major categories of IEIs and strategies for the appropriate diagnosis and management of these disorders.https://doi.org/10.1186/s13223-024-00938-z
spellingShingle Vy H. D. Kim
Julia E. M. Upton
Beata Derfalvi
Kyla J. Hildebrand
Christine McCusker
Inborn errors of immunity (primary immunodeficiencies)
Allergy, Asthma & Clinical Immunology
title Inborn errors of immunity (primary immunodeficiencies)
title_full Inborn errors of immunity (primary immunodeficiencies)
title_fullStr Inborn errors of immunity (primary immunodeficiencies)
title_full_unstemmed Inborn errors of immunity (primary immunodeficiencies)
title_short Inborn errors of immunity (primary immunodeficiencies)
title_sort inborn errors of immunity primary immunodeficiencies
url https://doi.org/10.1186/s13223-024-00938-z
work_keys_str_mv AT vyhdkim inbornerrorsofimmunityprimaryimmunodeficiencies
AT juliaemupton inbornerrorsofimmunityprimaryimmunodeficiencies
AT beataderfalvi inbornerrorsofimmunityprimaryimmunodeficiencies
AT kylajhildebrand inbornerrorsofimmunityprimaryimmunodeficiencies
AT christinemccusker inbornerrorsofimmunityprimaryimmunodeficiencies